Isocitrate dehydrogenase-1 (IDH1) inhibitors
- Name
- Isocitrate dehydrogenase-1 (IDH1) inhibitors
- Accession Number
- DBCAT005660
- Description
Not Available
- Drugs
Drug Drug Description Ivosidenib An isocitrate dehydrogenase-1 inhibitor used to treat acute myeloid leukemia and cholangiocarcinoma in adults with a susceptible IDH1 mutation. Olutasidenib An isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation as detected by an FDA-approved test. Vorasidenib A isocitrate dehydrogenase type 1 (IDH1) and 2 (IDH2) inhibitor used to treat Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation. - Drugs & Drug Targets